 CAMBRIDGE, Mass., Jan. 04, 2023 GLOBE NEWSWIRE -- Voyager Therapeutics, Inc. Nasdaq: VYGR, a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced that CEO Alfred W. Sandrock, Jr., M.D., Ph.D., will present at the upcoming 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023, at 10:30 a.m. PT 1:30 p.m. ET. 